State Street Corp

13F Holdings History for ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA)

Symbol: ADMA on Nasdaq
Investment type: Equity / COMMON STOCK
Latest Disclosed Ownership: 12.1M shares
Security Ownership: 5.1%

Shares, Excluding Options vs Price

Value, Excluding Options

STATE STREET CORPORATION ownership in ADMA BIOLOGICS, INC. COMMON STOCK (ADMA)

2025-08-11 - STATE STREET CORPORATION has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 12.1M shares of ADMA BIOLOGICS, INC. COMMON STOCK (ADMA). This represents 5.1% percent ownership of the company. In their previous filing dated 2025-05-13, STATE STREET CORP had reported owning 11.4M shares, indicating an increase of 5.57% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
STATE STREET CORPORATION	5.1%	+6%	$256M	12.1M	+637,727	+5.57%	$21.20	13G	6/30/2025	11 Aug 2025 06:41:13
STATE STREET CORPORATION	4.8%		$231M	11.4M			$20.23	13G	3/31/2025	13 May 2025 10:22:05

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
6/30/2025	0.01%	+0%	$220M	12.1M	+637,727	+5.57%	$18.21	Q2 2025
3/31/2025	0.01%	0%	$227M	11.4M	-3,429,969		$19.84	Q1 2025
12/31/2024	0.01%	+0%	$255M	14.9M	+1,865,754	+14.3%	$17.15	Q4 2024
9/30/2024	0.01%	+0%	$260M	13M	+4,945,063	+61.4%	$19.99	Q3 2024
6/30/2024	0%	0%	$90.1M	8.06M	-2,493,423	-23.6%	$11.18	Q2 2024
3/31/2024	0%	+0%	$69.7M	10.6M	+1,069,763	+11.3%	$6.60	Q1 2024
12/31/2023	0%	0%	$42.9M	9.48M	-118,348	-1.23%	$4.52	Q4 2023
9/30/2023	0%	0%	$34.4M	9.6M	-911,965	-8.67%	$3.58	Q3 2023
6/30/2023	0%	0%	$38.8M	10.5M	-2,474,686	-19.1%	$3.69	Q2 2023
3/31/2023	0%	+0%	$43M	13M	+1,981,380	+18%	$3.31	Q1 2023
12/31/2022	0%	+0%	$42.7M	11M	+1,583,787	+16.8%	$3.88	Q4 2022
9/30/2022	0%	+0%	$22.9M	9.42M	+6,459,197	+218%	$2.43	Q3 2022
6/30/2022	0%	+0%	$5.87M	2.96M	+2,330,710	+368%	$1.98	Q2 2022
3/31/2022	0%	+0%	$1.16M	634K	+219,271	+52.9%	$1.83	Q1 2022
12/31/2021	0%		$584K	414K			$1.41	Q4 2021
9/30/2021	0%		$468K	414K	+5,100	+1.25%	$1.13	Q3 2021
6/30/2021	0%	0%	$655K	409K	-597,387	-59.4%	$1.60	Q2 2021
3/31/2021	0%	0%	$1.77M	1.01M	-80,648	-7.42%	$1.76	Q1 2021
12/31/2020	0%	0%	$2.12M	1.09M	-101,626	-8.55%	$1.95	Q4 2020
9/30/2020	0%	0%	$2.84M	1.19M	-46,254	-3.75%	$2.39	Q3 2020
6/30/2020	0%	+0%	$3.62M	1.24M	+42,583	+3.57%	$2.93	Q2 2020
3/31/2020	0%	+0%	$3.43M	1.19M	+349,110	+41.4%	$2.88	Q1 2020
12/31/2019	0%	+0%	$3.37M	843K	+146,962	+21.1%	$4.00	Q4 2019
9/30/2019	0%	+0%	$3.1M	696K	+299,511	+75.5%	$4.45	Q3 2019
6/30/2019	0%	+0%	$1.54M	397K	+80,740	+25.5%	$3.87	Q2 2019
3/31/2019	0%	+0%	$1.2M	316K	+5,068	+1.63%	$3.79	Q1 2019
12/31/2018	0%	+0%	$743K	311K	+24,639	+8.6%	$2.39	Q4 2018
9/30/2018	0%	+0%	$1.78M	286K	+9,441	+3.41%	$6.21	Q3 2018
6/30/2018	0%	+0%	$1.25M	277K	+277,005	NEW	$4.51	Q2 2018

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.